FR2364034A1 - Nouveau vaccin inactive de virus de la rhinopneumonie equine et sa preparation - Google Patents
Nouveau vaccin inactive de virus de la rhinopneumonie equine et sa preparationInfo
- Publication number
- FR2364034A1 FR2364034A1 FR7726509A FR7726509A FR2364034A1 FR 2364034 A1 FR2364034 A1 FR 2364034A1 FR 7726509 A FR7726509 A FR 7726509A FR 7726509 A FR7726509 A FR 7726509A FR 2364034 A1 FR2364034 A1 FR 2364034A1
- Authority
- FR
- France
- Prior art keywords
- virus
- preparation
- virus vaccine
- equine rhinopneumonia
- new inactive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/27—Equine rhinopneumonitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/82—Viral vaccine for equine species, e.g. horses
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Nouveau vaccin inactivé. Ce vaccin est obtenu en propageant un virus de la rhinopneumonie équine dans une lignée cellulaire diploïde de cheval, réceptive, descendant d'un individu unique, en récoltant le virus résultant dans un milieu exempt de sérum, en inactivant le virus et en neutralisant l'agent inactivateur, en concentrant le virus et en y ajoutant un adjuvant immunologique. Application à la protection de chevaux contre la maladie due au virus de la rhinopneumonie équine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/722,817 US4083958A (en) | 1976-09-13 | 1976-09-13 | Inactivated equine rhinopneumonitis virus vaccine and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2364034A1 true FR2364034A1 (fr) | 1978-04-07 |
FR2364034B1 FR2364034B1 (fr) | 1981-06-12 |
Family
ID=24903513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7726509A Granted FR2364034A1 (fr) | 1976-09-13 | 1977-08-31 | Nouveau vaccin inactive de virus de la rhinopneumonie equine et sa preparation |
Country Status (4)
Country | Link |
---|---|
US (1) | US4083958A (fr) |
DE (1) | DE2739439A1 (fr) |
FR (1) | FR2364034A1 (fr) |
GB (1) | GB1538704A (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4225582A (en) * | 1979-03-08 | 1980-09-30 | The University Of Illinois Foundation | Vaccine for equine rhinopneumonitis |
US4600711A (en) * | 1982-08-18 | 1986-07-15 | The University Of Kentucky Research Foundation | Composition for topical and infusion treatment of wounds and burns |
US4483851A (en) * | 1982-08-18 | 1984-11-20 | The University Of Kentucky Research Foundation | Treatment for contagious equine metritis |
US5084271B1 (en) * | 1984-09-11 | 1997-08-05 | Univ Melbourne | Vaccine for equine herpesvirus |
US4841023A (en) * | 1986-06-25 | 1989-06-20 | New York Blood Center, Inc. | Inactivation of viruses in labile protein-containing compositions using fatty acids |
US5853715A (en) * | 1996-08-16 | 1998-12-29 | Bayer Corporation | Cross-protective equine herpesvirus preparations and method of making and using the same |
US6803041B2 (en) | 2001-03-20 | 2004-10-12 | Boehringer Ingelheim Vetmedica, Inc. | Equine herpesvirus vaccine |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2003343A1 (fr) * | 1968-03-06 | 1969-11-07 | Behringwerke Ag |
-
1976
- 1976-09-13 US US05/722,817 patent/US4083958A/en not_active Expired - Lifetime
-
1977
- 1977-08-31 GB GB36378/77A patent/GB1538704A/en not_active Expired
- 1977-08-31 FR FR7726509A patent/FR2364034A1/fr active Granted
- 1977-09-01 DE DE19772739439 patent/DE2739439A1/de active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2003343A1 (fr) * | 1968-03-06 | 1969-11-07 | Behringwerke Ag |
Non-Patent Citations (1)
Title |
---|
CA1969 * |
Also Published As
Publication number | Publication date |
---|---|
FR2364034B1 (fr) | 1981-06-12 |
GB1538704A (en) | 1979-01-24 |
DE2739439A1 (de) | 1978-03-16 |
US4083958A (en) | 1978-04-11 |
DE2739439C2 (fr) | 1988-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU98106860A (ru) | Вакцина против гриппа | |
SE8800731L (sv) | Fenylkarbamat | |
DZ1067A1 (fr) | Nouvelles préparations pharmaceutiques à emission prolongée. | |
EA199800943A1 (ru) | Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы | |
DE3853210T2 (de) | Verwendung eines viralen glykoprotein-impstoffes für intranasale immunisierung gegen eine virusinfektion. | |
FR2364034A1 (fr) | Nouveau vaccin inactive de virus de la rhinopneumonie equine et sa preparation | |
NO872880L (no) | Fremgangsmte for fremstilling av difenylpropylamin-derivater. | |
BR1100202A (pt) | Derivados de amino-2 fenil-4 tiazol, seu processo de preparação e sua aplicação terapêutica | |
GB1272920A (en) | New thiosemicarbazides | |
ES336810A1 (es) | Un metodo para producir una cepa de celulas. | |
SE7512828L (sv) | Calicivirusvaccin | |
ES379641A1 (es) | Procedimiento de produccion de antigenos inactivos para preparados farmaceuticos. | |
GB1192576A (en) | Diagnostic Substance and Composition | |
ATE61522T1 (de) | Pharmazeutische zubereitung zur behandlung von tinea pedis. | |
IT943598B (it) | Processo per la preparazione di formulazioni stabili di nadh | |
GB1187830A (en) | Pharmaceutical Compositions comprising Polynucleotides | |
Jungeblut | Reverse Interference Between Simian and Murine Poliomyelitis Virus in Guinea Pigs. | |
DK299983A (da) | Racemiske eller optisk aktive apovincaminsyrederivater eller farmaceutisk aktive syreadditionssalte deraf, deres fremstilling og anvendelse | |
SU575096A1 (ru) | Способ стимул ции родовой де тельности | |
Goto et al. | Experimental studies on viricidal activity of nitrogen mustard derivatives on various animal viruses | |
YAMAZAKI et al. | Occurrence of the non-moulting tiny silkworms caused by inoculation of the flacherie (F) virus | |
JPS58126785A (ja) | ヒトrna型腫瘍ウイルスの誘導法 | |
JPS55111447A (en) | Novel 3-amino-4-homoisotwistane derivative | |
BE768813A (fr) | Acides aminoalkanoiques substitues, leurs sels acceptables pourl'usage pharmaceutique, leur preparation et leurs utilisations therapeutiques | |
FR2290220A2 (fr) | Nouveau vaccin antirabique |